"Nasal Mucosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
Descriptor ID |
D009297
|
MeSH Number(s) |
A04.531.520 A04.760.600 A10.615.550.760.600
|
Concept/Terms |
Nasal Mucosa- Nasal Mucosa
- Mucosa, Nasal
- Schneiderian Membrane
- Membrane, Schneiderian
- Membranes, Schneiderian
- Schneiderian Membranes
|
Below are MeSH descriptors whose meaning is more general than "Nasal Mucosa".
Below are MeSH descriptors whose meaning is more specific than "Nasal Mucosa".
This graph shows the total number of publications written about "Nasal Mucosa" by people in this website by year, and whether "Nasal Mucosa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 3 | 4 |
1997 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 1 | 2 | 3 |
2006 | 1 | 1 | 2 |
2007 | 2 | 1 | 3 |
2009 | 2 | 3 | 5 |
2010 | 4 | 1 | 5 |
2011 | 4 | 2 | 6 |
2012 | 1 | 0 | 1 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nasal Mucosa" by people in Profiles.
-
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature. 2023 Mar; 615(7950):134-142.
-
Nasal Cauterization with Silver Nitrate for Recurrent Epistaxis. N Engl J Med. 2021 Jun 24; 384(25):e101.
-
Spaceflight-Associated Changes in the Opacification of the Paranasal Sinuses and Mastoid Air Cells in Astronauts. JAMA Otolaryngol Head Neck Surg. 2020 06 01; 146(6):571-577.
-
C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis. Mucosal Immunol. 2018 09; 11(5):1375-1385.
-
Mucous Cytokine Levels in Chronic Rhinosinusitis-Associated Olfactory Loss. JAMA Otolaryngol Head Neck Surg. 2016 08 01; 142(8):731-7.
-
Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with a nonantibiotic, alcohol-based nasal antiseptic. Am J Infect Control. 2014 Aug; 42(8):841-6.
-
Cytokine correlation between sinus tissue and nasal secretions among chronic rhinosinusitis and controls. Laryngoscope. 2013 Dec; 123(12):E72-8.
-
Characterization of B-cell subpopulations in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2013 Aug; 3(8):621-9.
-
Vitamin D3 deficiency increases sinus mucosa dendritic cells in pediatric chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg. 2012 Oct; 147(4):773-81.
-
Molecular characterization and antimicrobial susceptibility of nasal Staphylococcus aureus isolates from a Chinese medical college campus. PLoS One. 2011; 6(11):e27328.